awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55053748-9DE5D5AD-EBC5-4D0A-82DC-2B0657BDC5CA
Q55053748-9DE5D5AD-EBC5-4D0A-82DC-2B0657BDC5CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-9DE5D5AD-EBC5-4D0A-82DC-2B0657BDC5CA
Sorafenib in the treatment of thyroid cancer.
P2860
Q55053748-9DE5D5AD-EBC5-4D0A-82DC-2B0657BDC5CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-9DE5D5AD-EBC5-4D0A-82DC-2B0657BDC5CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f4201798c0fc613be81822fe54759ae460fdb41
P2860
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.